XML 90 R67.htm IDEA: XBRL DOCUMENT
v3.21.1

Stock Options and Warrants (Details Narrative) - USD ($) |  |  |  | 1 Months Ended | 3 Months Ended | 12 Months Ended |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Nov. 09, 2020 | Jun. 01, 2018 | Oct. 31, 2017 | Oct. 02, 2020 | Jul. 07, 2020 | May 14, 2020 | Aug. 31, 2019 | May 31, 2019 | Mar. 31, 2019 | Feb. 28, 2019 | Oct. 31, 2017 | Mar. 31, 2021 | Mar. 31, 2020 | Dec. 31, 2020 | Dec. 31, 2019 | Jun. 30, 2020 | May 31, 2020 | May 28, 2020 | Oct. 24, 2017
Number of shares authorized under 2014 plan (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 6,385 |  |  |  |  |
Common stock, shares authorized (in Shares) |  |  |  |  |  |  |  |  |  |  |  | 250,000,000 |  | 250,000,000 | 250,000,000 |  |  |  |
Equity incentive plan increased shares (in Shares) |  |  | 1,098,959 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 2.24 |  |  |  |  |
Award grant date value (in Dollars) |  |  |  | $ 3 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options with an exercise price (in Shares) |  |  |  |  | 250,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Additional units vesting term |  |  |  |  | 2 years |  |  |  |  |  |  |  |  |  |  |  |  |  |
Compensation expense (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 11,110 | $ 54,738 |  |  |  |
Warrants exercise price (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 2.00 |
Exercise price (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 4.27 |  |  |  |  |
Other expense (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,275,479 |  |  |  |  |
(in Dollars) |  |  |  |  |  |  |  |  |  |  |  | $ 1,309,212 | $ 31,976 | 1,840,745 | 39,372 |  |  |  |
Initial derivative expense (in Dollars) |  |  |  |  |  |  |  |  |  |  |  | $ 3,585,983 | $ 0 | $ 3,340,554 |  |  |  |  |
Weighted average remaining life |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 years 284 days |  |  |  |  |
Minimum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, shares authorized (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 31,250,000 |  |  |  |  |
Warrant (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 479,533 |  |  |  |  |
Maximum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, shares authorized (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 250,000,000 |  |  |  |  |
Warrant (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,438,599 |  |  |  |  |
Convertible Debenture Warrants and Placement Agent Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Dividend yield |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% |  |  |  |  |
Risk free interest rate |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.22% |  |  |  |  |
Fair value of warrants at inception (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 4,665,877 |  |  |  |  |
Number of warrants issued, shares (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,845,703 |  |  |  |  |
(in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,325,323 |  |  |  |  |
Initial derivative expense (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 3,340,554 |  |  |  |  |
Convertible Debenture Warrants and Placement Agent Warrants | Minimum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Volatility factor |  |  |  |  |  |  |  |  |  |  |  |  |  | 252.00% |  |  |  |  |
weighted average remaining life |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 years 339 days |  |  |  |  |
Convertible Debenture Warrants and Placement Agent Warrants | Maximum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Volatility factor |  |  |  |  |  |  |  |  |  |  |  |  |  | 341.00% |  |  |  |  |
weighted average remaining life |  |  |  |  |  |  |  |  |  |  |  |  |  | 3 years |  |  |  |  |
Convertible Debenture Warrants and Placement Agent Warrants One |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Dividend yield |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% |  |  |  |  |
Risk free interest rate |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.22% |  |  |  |  |
Fair value of warrants at inception (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 933,177 |  |  |  |  |
Number of warrants issued, shares (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 369,141 |  |  |  |  |
Debt discount (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 933,177 |  |  |  |  |
Convertible Debenture Warrants and Placement Agent Warrants One | Minimum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Volatility factor |  |  |  |  |  |  |  |  |  |  |  |  |  | 252.00% |  |  |  |  |
weighted average remaining life |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 years 339 days |  |  |  |  |
Convertible Debenture Warrants and Placement Agent Warrants One | Maximum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Volatility factor |  |  |  |  |  |  |  |  |  |  |  |  |  | 341.00% |  |  |  |  |
weighted average remaining life |  |  |  |  |  |  |  |  |  |  |  |  |  | 3 years |  |  |  |  |
Convertible Debenture Warrants and Placement Agent Warrants Two |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Dividend yield |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% |  |  |  |  |
Volatility factor |  |  |  |  |  |  |  |  |  |  |  |  |  | 228.00% |  |  |  |  |
Risk free interest rate |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.15% |  |  |  |  |
weighted average remaining life |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 years 146 days |  |  |  |  |
Fair value of warrants at inception (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 6,874,533 |  |  |  |  |
2017 Equity Plan |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, shares authorized (in Shares) |  |  | 475,000 |  |  |  |  |  |  |  | 475,000 |  |  |  |  |  |  |  |
Option granted, description |  |  |  |  |  |  |  |  |  |  | Any option granted under the 2017 Plan must provide for an exercise price of not less than 100% of the fair market value of the underlying shares on the date of grant and not less than $1.60 per share, but the exercise price of any ISO granted to an eligible employee owning more than 10% of our outstanding common stock must not be less than 110% of fair market value on the date of the grant. The plans further provide that with respect to ISOs the aggregate fair market value of the common stock underlying the options which are exercisable by any option holder during any calendar year cannot exceed $100,000. |  |  |  |  |  |  |  |
Terms of grants, description |  |  |  |  |  |  |  |  |  |  | The term of each plan option and the manner in which it may be exercised is determined by the Board or the Compensation Committee, provided that no option may be exercisable more than 10 years after the date of its grant and, in the case of an incentive option granted to an eligible employee owning more than 10% of the common stock, no more than five years after the date of the grant. |  |  |  |  |  |  |  |
Number of shares authorized by the plan (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,270,000 |  |  |  |  |
Options granted to purchase common stock (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 301,327 |  |  |  |
Exercise price (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1.45 |  |  |  |
Award grant date value (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 435,969 |  |  |  |  |
Compensation expense over vesting period (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 145,323 | $ 148,118 |  |  |  |
Description of vesting options |  |  |  |  |  |  |  |  |  |  |  |  |  |  | The options vest one third upon grants, one third on the first grant date anniversary and one third on the second grant date anniversary, subject to continued service by the directors and officers of the Company in their respective capacities as of each applicable vesting date. |  |  |  |
Options | 2017 Equity Plan |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, shares authorized (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,714,000 |  |
Options | 2017 Equity Plan |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options granted to purchase common stock (in Shares) |  |  |  |  |  |  | 31,250 |  |  |  |  |  |  |  |  |  |  |  |
Award grant date value (in Dollars) |  |  |  |  |  |  | $ 98,500 |  |  |  |  |  |  |  |  |  |  |  |
Dividend yield |  |  |  |  |  |  | 0.00% |  |  |  |  |  |  |  |  |  |  |  |
Volatility factor |  |  |  |  |  |  | 427.00% |  |  |  |  |  |  |  |  |  |  |  |
Risk free interest rate |  |  |  |  |  |  | 1.68% |  |  |  |  |  |  |  |  |  |  |  |
weighted average remaining life |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |
Description of vesting options |  |  |  |  |  |  | The options vest in full on May 23, 2020, subject to continued service as an advisor to the Company as of the vesting date. |  |  |  |  |  |  |  |  |  |  |  |
Share-based Compensation Arrangement by Share-based Payment Award, Description |  |  |  |  |  |  |  |  |  |  |  |  |  | As of December 31, 2020, there was approximately $1,344,000 of total unrecognized compensation cost related to non-vested stock options which vest over time and is expected to be recognized over a period of three years, as follows: 2021, $808,000; 2022, $429,000 and 2023, $107,000. |  |  |  |  |
Unrecognized compensation costs (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,344,000 |  |  |  |  |
Unrecognized compensation cost during fiscal 2021 (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | 808,000 |  |  |  |  |
Unrecognized compensation cost during fiscal 2022 (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | 429,000 |  |  |  |  |
Unrecognized compensation cost during fiscal 2023 (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | 107,000 |  |  |  |  |
Intrinsic value (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,426,230 |  |  |  |  |
Intrinsic value, exercisable (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | 603,819 |  |  |  |  |
Employee | Options | 2017 Equity Plan |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options granted to purchase common stock (in Shares) | 35,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price (in Dollars per share) | $ 1.85 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options term | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Award grant date value (in Dollars) | $ 64,743 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Compensation expense over vesting period (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | 4,586 |  |  |  |  |
Dividend yield | 0.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Volatility factor | 345.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Risk free interest rate | 0.44% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
weighted average remaining life | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Description of vesting options | The options will vest quarterly over three years. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Board of Directors Chairman | Options | 2017 Equity Plan |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options granted to purchase common stock (in Shares) |  |  |  |  |  |  |  | 451,170 |  | 43,423 |  |  |  |  |  |  |  |  |
Exercise price (in Dollars per share) |  |  |  |  |  |  |  | $ 6.40 |  | $ 3.52 |  |  |  |  |  |  |  |  |
Options term |  |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |
Award grant date value (in Dollars) |  |  |  |  |  |  |  | $ 2,217,952 |  | $ 149,730 |  |  |  |  |  |  |  |  |
Compensation expense over vesting period (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | 58,228 | $ 91,502 |  |  |  |
Dividend yield |  |  |  |  |  |  |  | 0.00% |  | 0.00% |  |  |  |  |  |  |  |  |
Volatility factor |  |  |  |  |  |  |  | 220.00% |  | 397.00% |  |  |  |  |  |  |  |  |
Risk free interest rate |  |  |  |  |  |  |  | 2.26% |  | 2.54% |  |  |  |  |  |  |  |  |
weighted average remaining life |  |  |  |  |  |  |  | 1 year 6 months |  | 1 year 6 months |  |  |  |  |  |  |  |  |
Description of vesting options |  |  |  |  |  |  |  | In May 2019, the Company granted to its Executive Chairman five-year options to purchase 451,170 common shares at $6.40 per share, which options shall vest subject to serving as Executive Chairman on November 14, 2020. |  |  |  |  |  |  |  |  |  |  |
Board of Directors Chairman | Stock Awards | 2017 Equity Plan |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Compensation expense over vesting period (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,293,805 | 924,147 |  |  |  |
Director | Options | 2017 Equity Plan |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options granted to purchase common stock (in Shares) |  |  |  | 50,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price (in Dollars per share) |  |  |  | $ 2.00 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options term |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Award grant date value (in Dollars) |  |  |  | $ 79,990 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Compensation expense over vesting period (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 13,332 |  |  |  |  |
Dividend yield |  |  |  | 0.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Volatility factor |  |  |  | 345.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Risk free interest rate |  |  |  | 0.27% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
weighted average remaining life |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Description of vesting options |  |  |  | The options will vest quarterly over three years with the first vesting on date of grant. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vice President | Options | 2017 Equity Plan |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options term |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |
Dividend yield |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% |  |  |  |  |
Volatility factor |  |  |  |  |  |  |  |  |  |  |  |  |  | 344.00% |  |  |  |  |
Risk free interest rate |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.31% |  |  |  |  |
weighted average remaining life |  |  |  |  |  |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |
Vice President | Options | 2017 Equity Plan |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options granted to purchase common stock (in Shares) |  |  |  |  | 250,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price (in Dollars per share) |  |  |  |  | $ 1.85 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options term |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |
Award grant date value (in Dollars) |  |  |  |  | $ 462,447 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Compensation expense over vesting period (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 231,224 |  |  |  |  |
Dividend yield |  |  |  |  |  | 0.00% |  |  |  |  |  |  |  |  |  |  |  |  |
Volatility factor |  |  |  |  |  | 345.00% |  |  |  |  |  |  |  |  |  |  |  |  |
Risk free interest rate |  |  |  |  |  | 0.31% |  |  |  |  |  |  |  |  |  |  |  |  |
weighted average remaining life |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |
Description of vesting options |  |  |  |  | The options will vest in twelve equal monthly installments on the last calendar day of each calendar month, with the first portion vesting on July 31, 2020, subject to continued employment with the Company. |  |  |  |  |  |  |  |  |  |  |  |  |  |
Chief Financial Officer | Options | 2017 Equity Plan |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options term |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |
Chief Financial Officer | Options | 2017 Equity Plan |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options granted to purchase common stock (in Shares) |  |  |  |  |  | 26,087 |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price (in Dollars per share) |  |  |  |  |  | $ 2.50 |  |  |  |  |  |  |  |  |  |  |  |  |
Award grant date value (in Dollars) |  |  |  |  |  | $ 65,210 |  |  |  |  |  |  |  |  |  |  |  |  |
Compensation expense over vesting period (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | 65,210 |  |  |  |  |
Description of vesting options |  |  |  |  |  | The options will vest in six equal monthly installments on the last calendar day of each calendar month, with the first portion vesting on May 31, 2020, subject to serving as the Chief Financial Officer of the Company on each applicable vesting date, provided that the options shall vest in full upon the listing of the Company’s securities on NYSE American or the Nasdaq Capital Market. |  |  |  |  |  |  |  |  |  |  |  |  |
Consultants | Options | 2017 Equity Plan |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Compensation expense over vesting period (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | 47,987 | $ 50,513 |  |  |  |
Volatility factor |  |  |  |  |  | 250.00% |  |  |  |  |  |  |  |  |  |  |  |  |
Risk free interest rate |  |  |  |  |  | 0.15% |  |  |  |  |  |  |  |  |  |  |  |  |
weighted average remaining life |  |  |  |  |  | 3 years |  |  |  |  |  |  |  |  |  |  |  |  |
Consultants | Options | 2017 Equity Plan |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options granted to purchase common stock (in Shares) |  |  |  |  |  | 25,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price (in Dollars per share) |  |  |  |  |  | $ 2.50 |  |  |  |  |  |  |  |  |  |  |  |  |
Options term |  |  |  |  |  | 1 year |  |  |  |  |  |  |  |  |  |  |  |  |
Award grant date value (in Dollars) |  |  |  |  |  | $ 49,304 |  |  |  |  |  |  |  |  |  |  |  |  |
Compensation expense over vesting period (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 49,304 |  |  |  |  |
Dividend yield |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% |  |  |  |  |
Volatility factor |  |  |  |  |  |  |  |  |  |  |  |  |  | 354.00% |  |  |  |  |
Risk free interest rate |  |  |  |  |  |  |  |  |  |  |  |  |  | 1.67% |  |  |  |  |
weighted average remaining life |  |  |  |  |  | 1 year |  |  |  |  |  |  |  |  |  |  |  |  |
Description of vesting options |  |  |  |  |  | The options vested in full upon completion of a certain project, which occurred in the third quarter of 2020. |  |  |  |  |  |  |  |  |  |  |  |  |
Chief Financial Officer One | Options | 2017 Equity Plan |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options granted to purchase common stock (in Shares) |  |  |  |  |  | 431,251 |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price (in Dollars per share) |  |  |  |  |  | $ 2.50 |  |  |  |  |  |  |  |  |  |  |  |  |
Options term |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |
Award grant date value (in Dollars) |  |  |  |  |  | $ 1,077,999 |  |  |  |  |  |  |  |  |  |  |  |  |
Compensation expense over vesting period (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 234,348 |  |  |  |  |
Dividend yield |  |  |  |  |  | 0.00% |  |  |  |  |  |  |  |  |  |  |  |  |
Volatility factor |  |  |  |  |  | 344.00% |  |  |  |  |  |  |  |  |  |  |  |  |
Risk free interest rate |  |  |  |  |  | 0.31% |  |  |  |  |  |  |  |  |  |  |  |  |
weighted average remaining life |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |
Series A1 Convertible Redeemable Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
weighted average remaining life |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercise price (in Dollars per share) |  | $ 0.80 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Series D Preferred Stock | Minimum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercise price (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 4.80 |  |  |  |  |
Warrants issued (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 8,594 |  |  |  |  |
Series D Preferred Stock | Maximum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options term |  |  |  |  |  |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |
Dividend yield |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% |  |  |  |  |
Volatility factor |  |  |  |  |  |  |  |  |  |  |  |  |  | 344.00% |  |  |  |  |
Risk free interest rate |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.34% |  |  |  |  |
Warrants exercise price (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1.60 |  |  |  |  |
Warrants issued (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 26,465 |  |  |  |  |
Series D Preferred Stock | Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock purchase warrants (in Shares) |  |  |  |  |  |  |  |  | 2,250,000 |  |  |  |  |  |  |  |  |  |
Warrants exercise price (in Dollars per share) |  |  |  |  |  |  |  |  | $ 0.80 |  |  |  |  |  |  |  |  |  |
Expire date |  |  |  |  |  |  |  |  | Sep. 01, 2023 |  |  |  |  |  |  |  |  |  |
Warrants issued (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 470,939 |  |  |  |
Exercise price (in Dollars per share) |  |  |  |  |  |  |  |  | $ 4.80 |  |  |  |  |  | $ 4.80 |  |  |  |
Change in derivative value of other expenses (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,642,175 |  |  |  |  |
Other expense (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,382,782 |  |  |  |  |
Other income (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,138,604 |  |  |  |  |
Fair value of derivative liability (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 4,663,464 |  |  |  |  |
Series D Preferred Stock | Warrants | Minimum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Volatility factor |  |  |  |  |  |  |  |  |  |  |  |  |  | 230.00% |  |  |  |  |
Risk free interest rate |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.17% |  |  |  |  |
weighted average remaining life |  |  |  |  |  |  |  |  |  |  |  |  |  | 3 years 73 days |  |  |  |  |
Series D Preferred Stock | Warrants | Maximum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Volatility factor |  |  |  |  |  |  |  |  |  |  |  |  |  | 340.00% |  |  |  |  |
Risk free interest rate |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.36% |  |  |  |  |
weighted average remaining life |  |  |  |  |  |  |  |  |  |  |  |  |  | 4 years 146 days |  |  |  |  |
Series D Preferred Stock | 2017 Equity Plan |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares authorized by the plan (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,770,000 |  |  |
Series D Preferred Stock One | Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Dividend yield |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% | 0.00% |  |  |  |
Volatility factor |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 366.00% |  |  |  |
Risk free interest rate |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1.655% |  |  |  |
Fair value of derivative liability (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 612,042 |  |  |  |
Series D Preferred Stock One | Warrants | Minimum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
weighted average remaining life |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4 years 3 months |  |  |  |
Series D Preferred Stock One | Warrants | Maximum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
weighted average remaining life |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4 years 153 days |  |  |  |
Series A1 Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Dividend yield |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% |  |  |  |  |
Volatility factor |  |  |  |  |  |  |  |  |  |  |  |  |  | 380.00% |  |  |  |  |
Risk free interest rate |  |  |  |  |  |  |  |  |  |  |  |  |  | 2.74% |  |  |  |  |
weighted average remaining life |  |  |  |  |  |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |
Warrants issued (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 288,000 |  |  |  |  |
Series D Preferred Stock Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants issued (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,223,438 |  |  |  |  |
Common Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, shares authorized (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  | 250,000,000 |  |  |  |  |
Series A Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercise price (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 0.80

X
- References No definition available. + Details
Name: | RCRT_AdditionalUnitsVestingTerm
Namespace Prefix: | RCRT_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | RCRT_CompensationExpenseOverVestingPeriod
Namespace Prefix: | RCRT_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | RCRT_DebtDiscount
Namespace Prefix: | RCRT_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Unrecognized compensation cost during fiscal 2023. + References No definition available. + Details
Name: | RCRT_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedNextFourYears
Namespace Prefix: | RCRT_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Unrecognized compensation cost during fiscal 2022. + References No definition available. + Details
Name: | RCRT_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedNextThreeYears
Namespace Prefix: | RCRT_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Unrecognized compensation cost during fiscal 2021. + References No definition available. + Details
Name: | RCRT_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedNextTwoYears
Namespace Prefix: | RCRT_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- References No definition available. + Details
Name: | RCRT_EquityIncentivePlanIncreasedShares
Namespace Prefix: | RCRT_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Expense for change in value of the derivative during the period. + References No definition available. + Details
Name: | RCRT_ExpenseForChangeInValueOfDerivative
Namespace Prefix: | RCRT_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Fair value of warrants at inception. + References No definition available. + Details
Name: | RCRT_FairValueOfWarrantsAtInception
Namespace Prefix: | RCRT_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of initial derivative expense. + References No definition available. + Details
Name: | RCRT_InitialDerivativeExpense
Namespace Prefix: | RCRT_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of shares authorized under 2014 plan. + References No definition available. + Details
Name: | RCRT_NumberOfSharesAuthorizedUnder2014Plan
Namespace Prefix: | RCRT_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | RCRT_NumberOfWarrantsIssuedShares
Namespace Prefix: | RCRT_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition This amount is for potential options to be issued. + References No definition available. + Details
Name: | RCRT_PotentialOptionsToBeIssued
Namespace Prefix: | RCRT_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Value of the award at the time of grant. + References No definition available. + Details
Name: | RCRT_SharebasedCompensationArrangementBySharebasedPaymentAwardAtTheTimeOfGrant
Namespace Prefix: | RCRT_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Option granted, description. + References No definition available. + Details
Name: | RCRT_StockOptionGrantedDescription
Namespace Prefix: | RCRT_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Terms of grants, description. + References No definition available. + Details
Name: | RCRT_TermsOfGrantsDescription
Namespace Prefix: | RCRT_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrants issued. + References No definition available. + Details
Name: | RCRT_WarrantsIssued
Namespace Prefix: | RCRT_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | RCRT_WeightedAverageRemainingLife
Namespace Prefix: | RCRT_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.8) -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227 + Details
Name: | us-gaap_AmortizationOfDebtDiscountPremium
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Date the warrants or rights are exercisable, in CCYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644 + Details
Name: | us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockSharesAuthorized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586 + Details
Name: | us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 20 -Section 50 -Paragraph 3 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 20 -Section 55 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313 + Details
Name: | us-gaap_DerivativeLiabilities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of expense for employee benefit and equity-based compensation. + References No definition available. + Details
Name: | us-gaap_EmployeeBenefitsAndShareBasedCompensation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of cost not yet recognized for nonvested award under share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 480 -SubTopic 10 -Section 25 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875 + Details
Name: | us-gaap_FairValueAdjustmentOfWarrants
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of interest expense classified as other. + References No definition available. + Details
Name: | us-gaap_InterestExpenseOther
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of revenue and income classified as other. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.4) -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263 + Details
Name: | us-gaap_OtherIncome
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(iii) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(ii) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The risk-free interest rate assumption that is used in valuing an option on its own shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(iv) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares authorized for issuance under share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iii) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Net number of share options (or share units) granted during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(i) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14.D.2) -URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=RCRT_ConvertibleDebentureWarrantsAndPlacementAgentWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=RCRT_ConvertibleDebentureWarrantsAndPlacementAgentWarrantsOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=RCRT_ConvertibleDebentureWarrantsAndPlacementAgentWarrantsTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=RCRT_TwoThousandSeventeenEquityPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | RCRT_PeriodAxis=RCRT_TwoThousandSeventeenEquityPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=RCRT_EmployeeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DerivativeInstrumentRiskAxis=RCRT_StockAwardsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=srt_DirectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=srt_VicePresidentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=RCRT_consultantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=RCRT_ChiefFinancialOfficerOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=RCRT_SeriesA1ConvertibleRedeemablePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=RCRT_SeriesDPreferredStockOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=RCRT_SeriesA1PreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=RCRT_SeriesDPreferredStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |